(HealthDay)—A registry has been created for reporting skin manifestations of COVID-19 following reports of patients presenting with skin conditions, including findings outlined in a letter to the editor published online March 26 in the Journal of the European Academy of Dermatology and Venereology. Following reports of patients presenting with skin conditions, including rashes, upon diagnosis […]
Home »
Registry data—of sufficient quality—suitable for extended benefit assessment of drugs
Particularly in the case of accelerated drug approvals and drugs for rare diseases (orphan drugs), the evidence available at the time of market access is often insufficient for the early benefit assessment of drugs. Often, the studies are too short or no data on patient-relevant outcomes were collected. Comparisons with the German standard of care […]
Fighting cancer with cheap treatment and screening
Cancer is the most feared disease worldwide, and it is even more so in India where treatment outcomes are uncertain because of delayed diagnosis, patchy availability of specialised treatment and long and expensive therapies that most people without health insurance cannot afford. Cancer continues to be diagnosed in late stages, when treatment is more toxic […]